{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T03:49:39Z","timestamp":1782100179380,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018936","name":"Universit\u00e4tsklinikum Heidelberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018936","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>AIFM1<\/jats:italic>\n                      encodes the X-linked oxidoreductase \u2018apoptosis-inducing factor 1, mitochondrial\u2019 that mediates caspase-independent programmed cell death and is involved in redox metabolism. To date, cardiac involvement has been reported in four patients with\n                      <jats:italic>AIFM1<\/jats:italic>\n                      variants, primarily presenting as ventricular hypertrophy, but its clinical course and prognosis remain not well understood.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We report the first affected female with a heterozygous\n                      <jats:italic>AIFM1<\/jats:italic>\n                      variant who developed infantile-onset mitochondrial encephalomyopathy and cardiomyopathy with initial ventricular hypertrophy, that progressed to left ventricular dilation and chronic heart failure. In addition, we review the available literature on\n                      <jats:italic>AIFM1<\/jats:italic>\n                      -associated cardiomyopathy to contextualize clinical findings.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Genetic testing identified a heterozygous\n                      <jats:italic>AIFM1<\/jats:italic>\n                      variant, c.506C\u2009&gt;\u2009T (p.Pro169Leu), with extremely skewed X-inactivation (98:2) in a female. The patient presented with infantile-onset mitochondrial encephalomyopathy. Echocardiography at 8\u00a0months revealed marked left ventricular hypertrophy with preserved systolic function. During follow-up, the cardiac phenotype progressively evolved into dilated cardiomyopathy with systolic dysfunction by 2.5\u00a0years of age, necessitating initiation of heart failure therapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      A heterozygous\n                      <jats:italic>AIFM1<\/jats:italic>\n                      variant can result in disease manifestation in females. The phenotypic spectrum of\n                      <jats:italic>AIFM1<\/jats:italic>\n                      -related disease includes cardiomyopathy, typically characterized by early-onset cardiac hypertrophy that may progress to ventricular dilatation and heart failure. This case highlights the importance of early recognition and careful cardiac monitoring in affected individuals, including female variant carriers.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40348-026-00246-z","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T03:15:58Z","timestamp":1782098158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiomyopathy and mitochondrial encephalomyopathy in a female child associated with a heterozygous X-linked AIFM1 variant"],"prefix":"10.1186","volume":"13","author":[{"given":"Christoph","family":"Sandmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swathi","family":"Gudapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes A.","family":"Mayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami Abou","family":"Jamra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kovacevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Syrbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"246_CR1","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1016\/j.molcel.2025.05.036","volume":"85","author":"RA Rothemann","year":"2025","unstructured":"Rothemann RA, Pavlenko E, Mondal M et al (2025) Interaction with AK2A links AIFM1 to cellular energy metabolism. Mol Cell 85:2550-2566.e6. https:\/\/doi.org\/10.1016\/j.molcel.2025.05.036","journal-title":"Mol Cell"},{"key":"246_CR2","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1515\/hsz-2020-0254","volume":"402","author":"JM Herrmann","year":"2021","unstructured":"Herrmann JM, Riemer J (2021) Apoptosis inducing factor and mitochondrial NADH dehydrogenases: redox-controlled gear boxes to switch between mitochondrial biogenesis and cell death. Biol Chem 402:289\u2013297","journal-title":"Biol Chem"},{"key":"246_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ppedcard.2018.08.009","volume":"51","author":"G Norrish","year":"2018","unstructured":"Norrish G, Elliott PM (2018) Cardiomyopathies in children: mitochondrial and storage disease. Prog Pediatr Cardiol 51:16\u201323","journal-title":"Prog Pediatr Cardiol"},{"key":"246_CR4","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00392-025-02703-7","volume":"115","author":"F Minette","year":"2026","unstructured":"Minette F, Klass M, Meyer N et al (2026) Clinical characteristics and etiology-specific outcome in pediatric hypertrophic cardiomyopathy. Clin Res Cardiol 115:795\u2013810. https:\/\/doi.org\/10.1007\/s00392-025-02703-7","journal-title":"Clin Res Cardiol"},{"key":"246_CR5","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ymgme.2011.09.020","volume":"104","author":"I Berger","year":"2011","unstructured":"Berger I, Ben-Neriah Z, Dor-Wolman T et al (2011) Early prenatal ventriculomegaly due to an AIFM1 mutation identified by linkage analysis and whole exome sequencing. Mol Genet Metab 104:517\u2013520","journal-title":"Mol Genet Metab"},{"key":"246_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ejpn.2017.09.004","volume":"22","author":"G Heimer","year":"2018","unstructured":"Heimer G, Eyal E, Zhu X et al (2018) Mutations in AIFM1 cause an X-linked childhood cerebellar ataxia partially responsive to riboflavin. Eur J Paediatr Neurol 22:93\u2013101. https:\/\/doi.org\/10.1016\/j.ejpn.2017.09.004","journal-title":"Eur J Paediatr Neurol"},{"key":"246_CR7","doi-asserted-by":"publisher","unstructured":"Moss T, May M, Flanagan-Steet H, et al (2021) Severe multisystem pathology, metabolic acidosis, mitochondrial dysfunction, and early death associated with an X-linked AIFM1 variant. Molecular Case Studies 7:. https:\/\/doi.org\/10.1101\/mcs.a006081","DOI":"10.1101\/mcs.a006081"},{"key":"246_CR8","doi-asserted-by":"publisher","first-page":"10261","DOI":"10.1128\/MCB.25.23.10261-10272.2005","volume":"25","author":"N Joza","year":"2005","unstructured":"Joza N, Oudit GY, Brown D et al (2005) Muscle-specific loss of apoptosis-inducing factor leads to mitochondrial dysfunction, skeletal muscle atrophy, and dilated cardiomyopathy. Mol Cell Biol 25:10261\u201310272. https:\/\/doi.org\/10.1128\/MCB.25.23.10261-10272.2005","journal-title":"Mol Cell Biol"},{"key":"246_CR9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1023\/B:BOLI.0000031098.41409.55","volume":"27","author":"DR Thorburn","year":"2004","unstructured":"Thorburn DR (2004) Mitochondrial disorders: prevalence, myths and advances. J Inherit Metab Dis 27:349\u2013362","journal-title":"J Inherit Metab Dis"},{"key":"246_CR10","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1136\/jmg-2025-110696","volume":"62","author":"C Sandmann","year":"2025","unstructured":"Sandmann C, Klaassen S, Kaski JP et al (2025) Contemporary practice and resource availability for genetic testing in paediatric hypertrophic cardiomyopathy. J Med Genet 62:528\u2013530. https:\/\/doi.org\/10.1136\/jmg-2025-110696","journal-title":"J Med Genet"},{"key":"246_CR11","doi-asserted-by":"publisher","first-page":"4679","DOI":"10.1038\/sj.emboj.7600461","volume":"23","author":"N Vahsen","year":"2004","unstructured":"Vahsen N, Cand\u00e9 C, Bri\u00e8re J et al (2004) AIF deficiency compromises oxidative phosphorylation. EMBO J 23:4679\u20134689","journal-title":"EMBO J"},{"key":"246_CR12","doi-asserted-by":"publisher","unstructured":"Wischhof L, Scifo E, Ehninger D, Bano D (2022) AIFM1 beyond cell death: An overview of this OXPHOS-inducing factor in mitochondrial diseases. EBioMedicine 83:. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104231","DOI":"10.1016\/j.ebiom.2022.104231"},{"key":"246_CR13","doi-asserted-by":"publisher","first-page":"165746","DOI":"10.1016\/j.bbadis.2020.165746","volume":"1866","author":"C Reinhardt","year":"2020","unstructured":"Reinhardt C, Arena G, Nedara K et al (2020) AIF meets the CHCHD4\/Mia40-dependent mitochondrial import pathway. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1866:165746","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"key":"246_CR14","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.molcel.2015.04.020","volume":"58","author":"E Hangen","year":"2015","unstructured":"Hangen E, F\u00e9raud O, Lachkar S et al (2015) Interaction between AIF and CHCHD4 regulates respiratory chain biogenesis. Mol Cell 58:1001\u20131014. https:\/\/doi.org\/10.1016\/j.molcel.2015.04.020","journal-title":"Mol Cell"},{"key":"246_CR15","doi-asserted-by":"publisher","first-page":"e110784","DOI":"10.15252\/embj.2022110784","volume":"41","author":"SL Salscheider","year":"2022","unstructured":"Salscheider SL, Gerlich S, Cabrera\u2010Orefice A et al (2022) AIFM1 is a component of the mitochondrial disulfide relay that drives complex I assembly through efficient import of NDUFS5. EMBO J 41:e110784","journal-title":"EMBO J"},{"key":"246_CR16","doi-asserted-by":"publisher","first-page":"e2106950118","DOI":"10.1073\/PNAS.2106950118\/SUPPL_FILE\/PNAS.2106950118.SD05.XLSX","volume":"118","author":"JF Hevler","year":"2021","unstructured":"Hevler JF, Chiozzi RZ, Cabrera-Orefice A et al (2021) Molecular characterization of a complex of apoptosis-inducing factor 1 with cytochrome c oxidase of the mitochondrial respiratory chain. Proc Natl Acad Sci U S A 118:e2106950118. https:\/\/doi.org\/10.1073\/PNAS.2106950118\/SUPPL_FILE\/PNAS.2106950118.SD05.XLSX","journal-title":"Proc Natl Acad Sci U S A"},{"key":"246_CR17","doi-asserted-by":"publisher","unstructured":"Morton SU, Prabhu SP, Lidov HGW, et al (2017) AIFM1 mutation presenting with fatal encephalomyopathy and mitochondrial disease in an infant. Molecular Case Studies 3:. https:\/\/doi.org\/10.1101\/mcs.a001560","DOI":"10.1101\/mcs.a001560"},{"key":"246_CR18","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/ejhg.2015.141","volume":"24","author":"D Diodato","year":"2016","unstructured":"Diodato D, Tasca G, Verrigni D et al (2016) A novel AIFM1 mutation expands the phenotype to an infantile motor neuron disease. Eur J Hum Genet 24:463\u2013466. https:\/\/doi.org\/10.1038\/ejhg.2015.141","journal-title":"Eur J Hum Genet"},{"key":"246_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ebiom.2018.03.016","volume":"30","author":"D Bano","year":"2018","unstructured":"Bano D, Prehn JHM (2018) Apoptosis-Inducing Factor (AIF) in physiology and disease: the tale of a repented natural born killer. EBioMedicine 30:29\u201337. https:\/\/doi.org\/10.1016\/j.ebiom.2018.03.016","journal-title":"EBioMedicine"},{"key":"246_CR20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s12017-023-08750-5","volume":"25","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Lin Y, Wang B et al (2023) A missense variant in AIFM1 caused mitochondrial dysfunction and intolerance to riboflavin deficiency. Neuromol Med 25:489\u2013500. https:\/\/doi.org\/10.1007\/s12017-023-08750-5","journal-title":"Neuromol Med"},{"key":"246_CR21","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ajhg.2010.03.002","volume":"86","author":"D Ghezzi","year":"2010","unstructured":"Ghezzi D, Sevrioukova I, Invernizzi F et al (2010) Severe X-Linked mitochondrial encephalomyopathy associated with a mutation in Apoptosis-Inducing Factor. Am J Hum Genet 86:639\u2013649. https:\/\/doi.org\/10.1016\/j.ajhg.2010.03.002","journal-title":"Am J Hum Genet"},{"key":"246_CR22","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.1161\/01.RES.0000172081.30327.28","volume":"96","author":"VPM van Empel","year":"2005","unstructured":"van Empel VPM, Bertrand AT, van der Nagel R et al (2005) Downregulation of Apoptosis-Inducing Factor in Harlequin mutant mice sensitizes the myocardium to oxidative stress-related cell death and pressure overload-induced decompensation. Circ Res 96:e92\u2013e101. https:\/\/doi.org\/10.1161\/01.RES.0000172081.30327.28","journal-title":"Circ Res"}],"container-title":["Molecular and Cellular Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40348-026-00246-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40348-026-00246-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40348-026-00246-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T03:16:00Z","timestamp":1782098160000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40348-026-00246-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["246"],"URL":"https:\/\/doi.org\/10.1186\/s40348-026-00246-z","relation":{},"ISSN":["2194-7791"],"issn-type":[{"value":"2194-7791","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"7 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been approved by the local ethics committee of Heidelberg University and has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}